Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "BioXcel"
showing the first 40- BioXcel Therapeutics, Inc. (BTAI)10-Q · 2022-08-11Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2024-10-09Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-Q · 2022-05-09Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)SCHEDULE 13G/A · 2025-05-15Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)DRS/A · 2017-12-26Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)DRS · 2017-11-13Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)DRS · 2017-11-13Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2021-03-11Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2021-03-01Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)S-1 · 2018-02-12Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-Q · 2018-05-14Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)S-1 · 2018-02-12Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)SC 13D/A · 2024-06-06Read the filing on SEC.gov →
- Mehta Vimal5 · 2021-02-16Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-Q · 2018-11-09Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-K/A · 2023-05-01Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-Q · 2024-08-06Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)S-1/A · 2018-02-27Read the filing on SEC.gov →
- Nandabalan Krishnan4 · 2021-06-29Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-K · 2021-03-12Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-K · 2020-03-09Read the filing on SEC.gov →
- BioXcel LLC4 · 2024-06-06Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)424B7 · 2024-06-04Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2019-03-25Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)SC 13G/A · 2021-02-16Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)SC 13G/A · 2023-02-14Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2020-04-15Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2018-04-26Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)SC 13D · 2023-09-28Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2018-07-24Read the filing on SEC.gov →
- Nandabalan Krishnan5 · 2023-02-14Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2018-10-30Read the filing on SEC.gov →
- Mehta Vimal4 · 2026-06-17Read the filing on SEC.gov →
- Mehta Vimal4 · 2020-05-13Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)S-1/A · 2018-02-26Read the filing on SEC.gov →
- Nandabalan Krishnan5 · 2022-02-14Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)10-K · 2019-03-12Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)8-K · 2023-11-14Read the filing on SEC.gov →
- BioXcel Therapeutics, Inc. (BTAI)DRS/A · 2018-01-26Read the filing on SEC.gov →
- Nandabalan Krishnan5 · 2021-02-16Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.